1. F.A. Kuehl Jr. andR.W. Egan,Prostaglandins, arachidonic acid and inflammation, Science210, 978–984 (1980).
2. H.J. Wedner, Cyclic nucleotides in the immune responses. InHandbook of Exp. Pharmacol., Vol. 58/II, pp. 763–785 (Eds.J.W. Kebabian andJ.A. Nathanson). Springer-Verlag, Berlin 1982.
3. H. Jacobi, H.-D. Dell andR. Kamp,Pharmacological and biochemical properties of 3-ethyl-1-(3-nitrophenyl)-2,4-[1H,3H]-quinazolindione in different animal species, Arch. Pharmacol.319, Suppl. R 3, 11 (1982).
4. B. Pelster, R. Fruchtmann, U. Krupka, H. Jacobi andH.-D. Dell,Pharmacological profile of TVX 2706, a non-acidic antiphlogistic active 1-arylquinazolindione, submitted for publication.
5. J.T. O'Flaherty, D.L. Kreutzer andP.A. Ward,Effect of prostaglandins E 1 ,E 2 and F 2α on neutrophil aggregation, Prostaglandins17, 201–210 (1979).